Genprex Inc
For the period ended Dec 31, 2023. Filed Apr 1, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Apr 1, 2024
GNPX$2.06-0.5%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
FINANCIAL STATEMENTS
GENPREX, INC.
INDEX TO FINANCIAL STATEMENTS
| Report of Independent Registered Public Accounting Firm (Auditor ID # 100) | F-2 |
|---|---|
| Report of Independent Registered Public Accounting Firm (Auditor ID # 0229) | F-3 |
| Balance Sheets - December 31, 2023 and 2022 | F-5 |
| Statements of Operations - December 31, 2023 and 2022 | F-6 |
| Statements of Changes in Stockholders’ Equity - December 31, 2023 and 2022 | F-7 |
| Statements of Cash Flows - December 31, 2023 and 2022 | F-8 |
| Notes to Financial Statements | F-9 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.